Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ciputra A Hartana, Ph.D., M.D.

Concepts (103)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Perforin220181711.360 Why?
Urinary Bladder Neoplasms6201820290.880 Why?
HIV-13202267570.760 Why?
CD8-Positive T-Lymphocytes4202242540.700 Why?
Transforming Growth Factor beta212018770.670 Why?
HIV Seropositivity120228930.630 Why?
Myeloid Cells120217870.590 Why?
Intercellular Adhesion Molecule-11201811640.520 Why?
Sentinel Lymph Node Biopsy120166540.440 Why?
HIV Infections32022155380.430 Why?
Immunologic Memory1201813910.420 Why?
Dendritic Cells1202127260.380 Why?
DNA Methylation2201840990.330 Why?
CD4-Positive T-Lymphocytes4202243830.310 Why?
Flow Cytometry1201661270.280 Why?
MicroRNAs1202136550.270 Why?
Carcinoma, Renal Cell1201629100.220 Why?
Gene Expression Regulation, Neoplastic1201886380.220 Why?
Proviruses120212720.200 Why?
Kidney Neoplasms1201639700.190 Why?
Oxidative Phosphorylation120214890.180 Why?
Signal Transduction22021239500.170 Why?
Interleukin-15120181660.170 Why?
Receptors, Antigen, T-Cell, alpha-beta120228210.160 Why?
Germinal Center120203630.160 Why?
Hematoxylin12016630.160 Why?
Eosine Yellowish-(YS)12016730.160 Why?
Glycolysis120218150.160 Why?
Keratin-1812016400.160 Why?
Urothelium120182850.150 Why?
Matrix Metalloproteinase 2120184740.140 Why?
Lymphocytes, Tumor-Infiltrating2201810600.140 Why?
Adenoma, Oxyphilic120161340.140 Why?
False Negative Reactions120166100.140 Why?
Histocompatibility Antigens Class I1202214180.140 Why?
T-Lymphocytes, Helper-Inducer120209970.130 Why?
Killer Cells, Natural1202221650.120 Why?
Viral Load1202132310.110 Why?
Antigens, Neoplasm2201920030.110 Why?
Urinary Bladder1201811250.110 Why?
Staining and Labeling1201611510.110 Why?
Cadherins120169210.110 Why?
Immunotherapy, Adoptive1201910170.100 Why?
Neoadjuvant Therapy2201825610.100 Why?
Epigenesis, Genetic2202134640.100 Why?
Alleles1202270900.100 Why?
Immunity, Innate1202229370.100 Why?
Antiviral Agents1202227680.100 Why?
T-Lymphocyte Subsets1201819240.090 Why?
Lymphocyte Activation2201859080.090 Why?
Lymphatic Metastasis1201629510.090 Why?
Cells, Cultured32018201700.080 Why?
B-Lymphocytes2202048610.080 Why?
Sequence Analysis, DNA1201849260.080 Why?
Antineoplastic Combined Chemotherapy Protocols22018112530.070 Why?
Tumor Escape220193280.070 Why?
Immunotherapy2201840570.070 Why?
Humans1320227088430.070 Why?
T-Lymphocytes, Regulatory1201830550.060 Why?
Neoplasm Proteins1201637730.060 Why?
Aged, 80 and over52020581840.060 Why?
Carcinoma, Squamous Cell1201838760.060 Why?
Infant, Newborn12022244330.060 Why?
Aged720201614880.060 Why?
Coronavirus Infections1202031530.060 Why?
Pneumonia, Viral1202032750.050 Why?
Male820213495240.050 Why?
T-Lymphocytes12019103620.050 Why?
Sensitivity and Specificity12016148360.050 Why?
Female820213752050.050 Why?
Middle Aged720202137520.050 Why?
Proto-Oncogene Proteins c-bcl-6120202000.050 Why?
Cell Line, Tumor12016169590.050 Why?
Prospective Studies22018505970.040 Why?
Muscle Neoplasms120181460.040 Why?
Tumor Necrosis Factor-alpha2202044660.040 Why?
Interleukin-13120183650.040 Why?
Sweden1201812900.040 Why?
Drug Therapy120185180.030 Why?
Spleen1202024730.030 Why?
CpG Islands1201811770.030 Why?
Cystectomy120186280.030 Why?
Antigen-Presenting Cells120169810.030 Why?
Interleukin-17120188940.030 Why?
Interleukin-101201612130.030 Why?
Forkhead Transcription Factors1201816000.030 Why?
Antigen Presentation1201613030.030 Why?
Neoplasms12019201720.030 Why?
Down-Regulation1201830930.020 Why?
Doxorubicin1201622350.020 Why?
Interferon-gamma1201832450.020 Why?
Chemotherapy, Adjuvant1201835150.020 Why?
Neoplasm Invasiveness1201836930.020 Why?
Cell Lineage1201826300.020 Why?
Neoplasm Staging12018111260.020 Why?
Randomized Controlled Trials as Topic1201994880.010 Why?
Treatment Outcome22018619320.010 Why?
Pandemics1202070890.010 Why?
Cell Differentiation12018117180.010 Why?
Case-Control Studies12018211940.010 Why?
Prognosis12018289190.010 Why?
Time Factors12018410380.010 Why?
Animals120191704860.000 Why?
Hartana's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (103)
Explore
_
Co-Authors (35)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.